Mission
PREECLAMPSIA FOUNDATION: 2025 IMPACT STATEMENT SAVING LIVES AND IMPROVING OUTCOMES FOR MOTHERS AND BABIES IN 2025, THE PREECLAMPSIA FOUNDATION CONTINUED ITS UNWAVERING MISSION TO REDUCE MATERNAL AND INFANT ILLNESS AND DEATH DUE TO HYPERTENSIVE DISORDERS OF PREGNANCY. WITH A CLEAR FOCUS ON HEALTH EQUITY, PATIENT EMPOWERMENT, AND RESEARCH ADVANCEMENT, WE MADE TRANSFORMATIONAL PROGRESS ACROSS ALL FOUR STRATEGIC PILLARS: EDUCATE, ENGAGE, EQUIP, AND ELEVATE. EDUCATE: WE REACHED HUNDREDS OF THOUSANDS OF PATIENTS AND PROFESSIONALS WITH CRITICAL, LIFE-SAVING INFORMATION. OVER 275,800 PATIENT EDUCATION MATERIALS WERE DISTRIBUTED, ARMING FAMILIES WITH THE KNOWLEDGE THEY NEED TO ADVOCATE FOR THEMSELVES. SIMULTANEOUSLY, WE TRAINED MORE THAN 400 HEALTHCARE PROVIDERS AND COMMUNITY HEALTH WORKERS, ENSURING EARLY DETECTION AND PROPER MANAGEMENT OF PREECLAMPSIA IN DIVERSE CLINICAL SETTINGS. ENGAGE: WITH 80 PATIENT-FAMILY PARTNER QUALITY IMPROVEMENT ENGAGEMENTS, WE DEEPENED OUR COMMITMENT TO PATIENT-CEN